Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of multiple chemotherapeutic agents for which there are currently no prevention strategies. The widely used chemotherapeutic paclitaxel causes CIPN, which involves degeneration of sensory axons in the skin and loss of sensation and ongoing pain in the hands and feet. Paclitaxel is known to bind and stabilize microtubules, but the cellular mechanisms that underlie paclitaxel’s neurotoxic effects are not well understood. To advance the understanding of molecular mechanisms of paclitaxel neurotoxicity, I used a culture system of clinically relevant adult mammalian sensory neurons to interrogate hypotheses for putative neurotoxic mechanisms. Paclitaxel expos...
Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel. For m...
Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel. For m...
Peripheral neuropathy is a dose-limiting side effect of anticancer treatment with the microtubule-ta...
Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers like breast, ovarian...
The overall goal of the experimental work undertaken in this thesis is to better understand the cell...
Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up to 60% of...
Paclitaxel is a common chemotherapeutic that often causes peripheral sensory neuropathy. Paclitaxel ...
Cancer patients undergoing paclitaxel infusion usually experience peripheral nerve degeneration and ...
Paclitaxel is a common chemotherapeutic that often causes peripheral sensory neuropathy. Paclitaxel ...
Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the che...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect from cancer treatment with ...
Peripheral neuropathy is a common side effect of paclitaxel. Clinical studies suggest that different...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect from cancer treatment with ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect from cancer treatment with ...
Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel. For m...
Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel. For m...
Peripheral neuropathy is a dose-limiting side effect of anticancer treatment with the microtubule-ta...
Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers like breast, ovarian...
The overall goal of the experimental work undertaken in this thesis is to better understand the cell...
Peripheral neuropathy is one of the most common side effects of chemotherapy, affecting up to 60% of...
Paclitaxel is a common chemotherapeutic that often causes peripheral sensory neuropathy. Paclitaxel ...
Cancer patients undergoing paclitaxel infusion usually experience peripheral nerve degeneration and ...
Paclitaxel is a common chemotherapeutic that often causes peripheral sensory neuropathy. Paclitaxel ...
Peripheral neuropathy (PN) is a debilitating and dose-limiting side effect of treatment with the che...
By 2030, 4 million people are estimated to survive cancer in the UK. Increased survival rates are th...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect from cancer treatment with ...
Peripheral neuropathy is a common side effect of paclitaxel. Clinical studies suggest that different...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect from cancer treatment with ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect from cancer treatment with ...
Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel. For m...
Peripheral neuropathy is a common dose-limiting toxicity for patients treated with paclitaxel. For m...
Peripheral neuropathy is a dose-limiting side effect of anticancer treatment with the microtubule-ta...